CurrentRheuma
Get Weekly

CurrentRheuma coverage · page 14 of 15

Osteoporosis International

Briefs 521–560 of 576 CurrentRheuma has covered from this journal, newest publication first

Latest from Osteoporosis International

All coverage, newest first

  1. Osteoporos Int

    Risk of fracture in neuromyelitis optica spectrum disorder and multiple sclerosis: a nationwide cohort study in South Korea

    Cohort study

  2. Osteoporos Int

    Exome-wide screening identifies novel rare risk variants for bone mineral density

    Research articleOsteoporosis

  3. Osteoporos Int

    Ethnic disparities in fracture risk assessment using polygenic scores

    Cohort studyOsteoporosis

  4. Osteoporos Int

    Risk of developing age-related macular degeneration in patients with osteoporosis: a population-based, longitudinal follow-up study

    Cohort studyOsteoporosis

  5. Osteoporos Int

    International consensus on the non-pharmacological and non-surgical management of osteoporotic vertebral fractures

    Guideline or statementOsteoporosis

  6. Osteoporos Int

    Impact of urinary calcium excretion on kidney, bone, and cardiovascular systems in patients with bone biopsy proven osteoporosis: a longitudinal long-term follow-up study

    Cohort studyOsteoporosis

  7. Osteoporos Int

    Lower incidence of hip fractures among elderly Ethiopian immigrants to Israel: first assessment from the Israel National Trauma Registry (INTR) 2011–2020

    Cohort studyOsteoporosis

  8. Osteoporos Int

    A nomogram for predicting residual low back pain after percutaneous kyphoplasty in osteoporotic vertebral compression fractures

    Cohort studyOsteoporosis

  9. Osteoporos Int

    Prevalence of osteoporosis and incidence of related fractures in developed economies in the Asia Pacific region: a systematic review

    Meta-analysisOsteoporosis

  10. Osteoporos Int

    National trends in osteoporosis medication use among Medicare beneficiaries with and without Alzheimer’s disease/related dementias

    Cohort studyOsteoporosis

  11. Osteoporos Int

    Fracture rate increases after immune checkpoint inhibitor treatment: a potential new immune related adverse event

    Cohort studyOsteoporosis

  12. Osteoporos Int

    Metabolic associated fatty liver disease and bone mineral density: a cross-sectional study of the National Health and Nutrition Examination Survey 2017–2018

    Cross-sectional studyOsteoporosis

  13. Osteoporos Int

    Prevention of aromatase inhibitor–induced bone loss with anti-resorptive therapy in post-menopausal women with early-stage breast cancer

    Cohort studyOsteoporosis

  14. Osteoporos Int

    The healthcare system costs of hip fracture care in South Africa

    Cohort studyOsteoporosis

  15. Osteoporos Int

    Implementation and operationalization of Integrated People-Centred Health Services delivery strategies in integrated osteoporosis care (IOC) initiatives: a systematic review

    Meta-analysisOsteoporosis

  16. Osteoporos Int

    Follicle-stimulating hormone is associated with low bone mass in postmenopausal women

    Cross-sectional studyOsteoporosis

  17. Osteoporos Int

    A summary of the Russian clinical guidelines on the diagnosis and treatment of osteoporosis

    Guideline or statementOsteoporosis

  18. Osteoporos Int

    The clinical utility of the BMD-related comprehensive genome-wide polygenic score in identifying individuals with a high risk of osteoporotic fractures

    Cohort studyOsteoporosis

  19. Osteoporos Int

    Nonoperative versus operative management of frail institutionalized older patients with a proximal femoral fracture: a cost-utility analysis alongside a multicenter prospective cohort study

    Cohort studyOsteoporosis

  20. Osteoporos Int

    A 3-year retrospective analysis of patients admitted with clinical vertebral fragility fractures across hospitals in England, UK

    Cohort studyOsteoporosis

  21. Osteoporos Int

    Bone loss after denosumab discontinuation is prevented by alendronate and zoledronic acid but not risedronate: a retrospective study

    Cohort studyOsteoporosis

  22. Osteoporos Int

    Are there specific clinical risk factors for the occurrence of multiple fractures? The FRISBEE study

    Cohort studyOsteoporosis

  23. Osteoporos Int

    The effectiveness and cost-effectiveness of clinical fracture-risk assessment tools in reducing future osteoporotic fractures among older adults: a structured scoping review

    Research articleOsteoporosis

  24. Osteoporos Int

    Meta-analysis of placebo-arm dropouts in osteoporosis randomized-controlled trials and implications for nocebo-associated discontinuation of anti-osteoporotic drugs in clinical practice

    Meta-analysisOsteoporosis

  25. Osteoporos Int

    Baseline serum PINP level is associated with the increase in hip bone mineral density seen with Romosozumab treatment in previously untreated women with osteoporosis

    Cohort studyOsteoporosis

  26. Osteoporos Int

    Prevalence of osteoporosis in older male veterans receiving hip-containing computed tomography scans: opportunistic use of biomechanical computed tomography analysis (BCT)

    Cross-sectional studyOsteoporosis

  27. Osteoporos Int

    C-reactive protein predicts endocortical expansion but not fracture in older men: the prospective STRAMBO study

    Cohort studyOsteoporosis

  28. Osteoporos Int

    Adjusting conventional FRAX estimates of fracture probability according to the number of prior falls in the preceding year

    Cohort studyOsteoporosis

  29. Osteoporos Int

    Changes in RANKL and TRAcP 5b after discontinuation of denosumab suggest RANKL mediated formation of osteoclasts results in the increased bone resorption

    Secondary analysisOsteoporosis

  30. Osteoporos Int

    A systematic review of cost‑effectiveness analyses of sequential treatment for osteoporosis

    Meta-analysisOsteoporosis

  31. Osteoporos Int

    Primary hyperparathyroidism and fracture probability

    Cohort studyOsteoporosis

  32. Osteoporos Int

    The high-risk hip fracture patient and the palliative care consult : A retrospective study to investigate risks of complications and the utility of a palliative care consult in hip fracture patients undergoing surgical fixation

    Cohort studyOsteoporosis

  33. Osteoporos Int

    Frailty and risk of subsequent fracture among older adults presenting to hospital with a minimal trauma fracture

    Cohort studyOsteoporosis

  34. Osteoporos Int

    Trends in anti-osteoporotic medication utilization following fragility fracture in the USA from 2011 to 2019

    Cohort studyOsteoporosis

  35. Osteoporos Int

    Variation in bone mineral density and fractures over 20 years among Canadians: a comparison of the Canadian Multicenter Osteoporosis Study and the Canadian Longitudinal Study on Aging

    Cohort studyOsteoporosis

  36. Osteoporos Int

    Fracture liaison service model: project design and accreditation

    Research articleOsteoporosis

  37. Osteoporos Int

    A low serum alkaline phosphatase may signal hypophosphatasia in osteoporosis clinic patients

    Cohort studyOsteoporosis

  38. Osteoporos Int

    Comparison of DXA-based versus CT-based indices to predict prevalent fracture history in men with spinal cord injury

    Diagnostic or prognostic studyOsteoporosis

  39. Osteoporos Int

    An Orthopaedic Surgeon Led Osteoporosis (OSLO) Model of Care reduces early recurrent fracture rates and improves treatment compliance in patients treated for osteoporotic fractures

    Cohort studyOsteoporosis

  40. Osteoporos Int

    Osteoporosis related to WNT1 variants: a not infrequent cause of osteoporosis

    Cohort studyOsteoporosis

All 576 Briefs in ExploreShowing Briefs 521–560 of 576, newest first